Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |